Skip to content
Taxonomy
Establishing gene therapy strategies for CMT2E
CMT2E is caused by dominant or recessive mutations in the Read More
CMTA Appoints David Apple to Board of Directors
GLENOLDEN, PA, USA, May 10, 2023, EINPresswire.com — Tech entrepreneur Read More
CMTA to attend the annual BIO partnering conference in Boston
The CMTA is a global leader in the acceleration of Read More
Sperm Donor with Gene for Charcot-Marie-Tooth Disease Passes It on to Multiple Families
GLENOLDEN, PA, USA, May 4, 2023, Newswire — The letter Read More
CMTA Adds Science Writer Kenneth Raymond to Team
On April 17, 2023, the Charcot-Marie-Tooth Association welcomed Kenneth Raymond Read More
CMTA Partnering is Open for Business
The CMTA is a global leader in the acceleration of Read More
CMTA Funds Preclinical Work on Modulating Unfolded Protein Response in CMT1B Mice
The Charcot-Marie-Tooth (CMT) Association announced a $33,000 grant on April Read More
CMTA Adds Drug Development Expert Martine Garnier to STAR Advisory Board
The Charcot-Marie-Tooth Association added to its already deep bench of Read More
Vera Fridman, MD joins the CMTA STAR Advisory Board
In a suite of exciting appointments, the Charcot-Marie-Tooth Association (CMTA) Read More
Bruce R Conklin, MD Joins the CMTA STAR Advisory Board
In a suite of exciting appointments, the Charcot-Marie-Tooth Association (CMTA) Read More
